Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Pediatric hypertension (PH) is an emerging global public health issue, increasingly linked to genetic, environmental, and lifestyle factors. Early-onset hypertension is associated with progressive long-term cardiovascular problems. This overview outlines the epidemiology, etiology, pathophysiology, treatment modalities, and current clinical studies related to hypertension in children and adolescents. A methodical search was conducted on PubMed, Scopus, and Web of Science using specific preset keywords. Recent high-quality peer-reviewed studies, trials, and reviews from the past decade were highlighted. The primary factors are genetic predisposition, renal artery stenosis, activation of the renin-angiotensin-aldosterone system (RAAS), obesity, metabolic syndrome, and sodium excess. Treatment involves lifestyle modifications and pharmacological intervention with ACE inhibitors, calcium channel blockers, beta-blockers, and diuretics. Recent clinical trials have provided insights into the safety and efficacy of therapies. The effective management of pediatric hypertension relies on prompt identification and individualized treatment. In future studies, priority should be given to precision medicine, long-term follow-up data, and the utilization of technological resources for surveillance.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021400792250807110550
2025-08-27
2025-12-18

  • From This Site

    /content/journals/chyr/10.2174/0115734021400792250807110550
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MillsK.T. StefanescuA. HeJ. The global epidemiology of hypertension.Nat. Rev. Nephrol.202016422323710.1038/s41581‑019‑0244‑2 32024986
     [Google Scholar]
  2. KhouryM. KhouryP. BazzanoL. Prevalence implications of the 2017 American Academy of Pediatrics hypertension guideline and associations with adult hypertension.J. Pediatr.20222412228.e410.1016/j.jpeds.2021.09.056 34619113
     [Google Scholar]
  3. SharmaA.K. MetzgerD.L. RoddC.J. Prevalence and severity of high blood pressure among children based on the 2017 American Academy of Pediatrics Guidelines.JAMA Pediatr.2018172655756510.1001/jamapediatrics.2018.0223 29710187
     [Google Scholar]
  4. MuntnerP. CareyR.M. GiddingS. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline.Circulation2018137210911810.1161/CIRCULATIONAHA.117.032582 29133599
     [Google Scholar]
  5. SongP. ZhangY. YuJ. Global prevalence of hypertension in children: A systematic review and meta-analysis.JAMA Pediatr.2019173121154116310.1001/jamapediatrics.2019.3310 31589252
     [Google Scholar]
  6. LibermanJ.N. BergerJ.E. LewisM. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.Arch. Pediatr. Adolesc. Med.2009163435736410.1001/archpediatrics.2009.5 19349565
     [Google Scholar]
  7. SkinnerA.C. RavanbakhtS.N. SkeltonJ.A. PerrinE.M. ArmstrongS.C. Prevalence of obesity and severe obesity in US children, 1999-2016.Pediatrics201814132017345910.1542/peds.2017‑3459 29483202
     [Google Scholar]
  8. HuK. StaianoA.E. Trends in obesity prevalence among children and adolescents aged 2 to 19 years in the US from 2011 to 2020.JAMA Pediatr.2022176101037103910.1001/jamapediatrics.2022.2052 35877133
     [Google Scholar]
  9. SouthA.M. GiammatteiV.C. BagleyK.W. The study of the epidemiology of pediatric hypertension registry (SUPERHERO): Rationale and methods.Am. J. Epidemiol.2024193121650166110.1093/aje/kwae116 38881045
     [Google Scholar]
  10. BendorC.D. BardugoA. Pinhas-HamielO. AfekA. TwigG. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity.Cardiovasc. Diabetol.20201917910.1186/s12933‑020‑01052‑1 32534575
     [Google Scholar]
  11. ThomasJ. StonebrookE. KallashM. Pediatric hypertension.Int. J. Pediatr. Adolesc. Med.2022911610.1016/j.ijpam.2020.09.005 35573063
     [Google Scholar]
  12. DionneJ.M. AbitbolC.L. FlynnJ.T. Hypertension in infancy: Diagnosis, management and outcome.Pediatr. Nephrol.2012271173210.1007/s00467‑010‑1755‑z 21258818
     [Google Scholar]
  13. MengY. MynardJ.P. SmithK.J. Pediatric blood pressure and cardiovascular health in adulthood.Curr. Hypertens. Rep.2024261143145010.1007/s11906‑024‑01312‑5 38878251
     [Google Scholar]
  14. BenensonI. WaldronF.A. PorterS. Pediatric hypertension.Nurse Pract.2020455162310.1097/01.NPR.0000660332.31690.68 32271260
     [Google Scholar]
  15. FlynnJ.T. KaelberD.C. Baker-SmithC.M. Clinical practice guideline for screening and management of high blood pressure in children and adolescents.Pediatrics201714032017190410.1542/peds.2017‑1904 28827377
     [Google Scholar]
  16. VieuxR. GerardM. RousselA. Kidneys in 5-year-old preterm-born children: A longitudinal cohort monitoring of renal function.Pediatr. Res.201782697998510.1038/pr.2017.148 28665930
     [Google Scholar]
  17. MacumberI. FlynnJ.T. Obesity hypertension: Clinical aspects.Pediatric Hypertension. FlynnJ.T. IngelfingerJ.R. BradyT.M. ChamSpringer202310.1007/978‑3‑031‑06231‑5_17
     [Google Scholar]
  18. ParkerE.D. SinaikoA.R. KharbandaE.O. Change in weight status and development of hypertension.Pediatrics201613732015166210.1542/peds.2015‑1662 26908707
     [Google Scholar]
  19. HanevoldC.D. FlynnJ.T. Hypertension in children: Diagnosis and treatment InHypertension.Amsterdam, NetherlandsElsevier202456457510.1016/B978‑0‑323‑88369‑6.00049‑9
     [Google Scholar]
  20. SheldonC.A. PaleyG.L. XiaoR. Pediatric idiopathic intracranial hypertension: Age, gender, and anthropometric features at diagnosis in a large, retrospective, multisite cohort.Ophthalmology2016123112424243110.1016/j.ophtha.2016.08.004 27692528
     [Google Scholar]
  21. Gupta-MalhotraM. BankerA. SheteS. Essential hypertension vs. secondary hypertension among children.Am. J. Hypertens.2015281738010.1093/ajh/hpu083 24842390
     [Google Scholar]
  22. ChrysaidouK. StabouliS. Treatment of hypertension induced target organ damage in children and adolescents.Curr. Pharm. Des.201924374378438410.2174/1381612825666181127095450 30479207
     [Google Scholar]
  23. GöknarN. ÇalışkanS. New guidelines for the diagnosis, evaluation, and treatment of pediatric hypertension.Turk. Pediatri Ars.2020551112210.14744/TurkPediatriArs.2020.92679
     [Google Scholar]
  24. ChrysaidouK. ChainoglouA. KaravaV. DotisJ. PrintzaN. StabouliS. Secondary hypertension in children and adolescents: Novel insights.Curr. Hypertens. Rev.2020161374410.2174/1573402115666190416152820 31038068
     [Google Scholar]
  25. SilversteinD.M. ChampouxE. AvilesD.H. VehaskariV.M. Treatment of primary and secondary hypertension in children.Pediatr. Nephrol.200621682082710.1007/s00467‑006‑0087‑5 16703375
     [Google Scholar]
  26. HavlikR.J. FeinleibM. Epidemiology and genetics of hypertension.Hypertension198245 Pt 2III121III127 7049926
     [Google Scholar]
  27. BironP. MongeauJ.G. BertrandD. Familial aggregation of blood pressure in 558 adopted children.Can. Med. Assoc. J.19761158773774 974967
     [Google Scholar]
  28. RobinsonC.H. ChanchlaniR. High blood pressure in children and adolescents: Current perspectives and strategies to improve future kidney and cardiovascular health.Kidney Int. Rep.20227595497010.1016/j.ekir.2022.02.018 35570999
     [Google Scholar]
  29. CaoY. YangS. YiliJ. Monogenic Hypertension InSecondary Hypertension: Screening, Diagnosis and Treatment.SingaporeSpringer Singapore2019639681
     [Google Scholar]
  30. ButlerM.G. Genetics of hypertension. Current status.J. Med. Liban.2010583175178PMC5132177
     [Google Scholar]
  31. RobinsonR. BatiskyD. HayesJ. NahataM. MahanJ. Significance of heritability in primary and secondary pediatric hypertension.Am. J. Hypertens.200518791792110.1016/j.amjhyper.2005.01.010 16053987
     [Google Scholar]
  32. PerrinE.C. SouthA.M. Correlation between kidney sodium and potassium handling and the renin-angiotensin-aldosterone system in children with hypertensive disorders.Pediatr. Nephrol.202237363364110.1007/s00467‑021‑05204‑7 34499251
     [Google Scholar]
  33. de Oliveira CamposJ.L. BitencourtL. PedrosaA.L. Renovascular hypertension in pediatric patients: Update on diagnosis and management.Pediatr. Nephrol.202136123853386810.1007/s00467‑021‑05063‑2 33851262
     [Google Scholar]
  34. SinghR.K. MeshramR.J. TiwariA. SinghR.K. A review of the mechanism of action of drugs used in congestive heart failure in pediatrics.Cureus20231513381110.7759/cureus.33811 36819391
     [Google Scholar]
  35. Guzman-LimonM. SamuelsJ. Pediatric hypertension.Pediatr. Clin. North Am.2019661455710.1016/j.pcl.2018.09.001 30454750
     [Google Scholar]
  36. DasguptaK. O’LoughlinJ. ChenS. Emergence of sex differences in prevalence of high systolic blood pressure: Analysis of a longitudinal adolescent cohort.Circulation2006114242663267010.1161/CIRCULATIONAHA.106.624536 17145992
     [Google Scholar]
  37. RedwineK.M. AcostaA.A. PoffenbargerT. PortmanR.J. SamuelsJ. Development of hypertension in adolescents with pre-hypertension.J. Pediatr.201216019810310.1016/j.jpeds.2011.07.010 21868037
     [Google Scholar]
  38. FalknerB. GiddingS.S. Ramirez-GarnicaG. WiltroutS.A. WestD. RappaportE.B. The relationship of body mass index and blood pressure in primary care pediatric patients.J. Pediatr.2006148219520010.1016/j.jpeds.2005.10.030 16492428
     [Google Scholar]
  39. LitwinM. KułagaZ. Obesity, metabolic syndrome, and primary hypertension.Pediatr. Nephrol.202136482583710.1007/s00467‑020‑04579‑3 32388582
     [Google Scholar]
  40. RizzoN.S. RuizJ.R. Hurtig-WennlöfA. OrtegaF.B. SjöströmM. Relationship of physical activity, fitness, and fatness with clustered metabolic risk in children and adolescents: The European youth heart study.J. Pediatr.2007150438839410.1016/j.jpeds.2006.12.039 17382116
     [Google Scholar]
  41. HendersonM. Van HulstA. von OettingenJ.E. BenedettiA. ParadisG. Normal weight metabolically unhealthy phenotype in youth: Do definitions matter?Pediatr. Diabetes201920214315110.1111/pedi.12785 30294842
     [Google Scholar]
  42. ReavenG. HoffmanB. A role for insulin in the aetiology and course of hypertension?Lancet1987330855643543710.1016/S0140‑6736(87)90968‑8 2887735
     [Google Scholar]
  43. GowrishankarM. BlairB. RiederM.J. Dietary intake of sodium by children: Why it matters.Paediatr. Child Health2020251475310.1093/pch/pxz153 32042243
     [Google Scholar]
  44. BalafaO. KalaitzidisR.G. Salt sensitivity and hypertension.J. Hum. Hypertens.202135318419210.1038/s41371‑020‑00407‑1 32862203
     [Google Scholar]
  45. WeinbergerM.H. FinebergN.S. FinebergS.E. WeinbergerM. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.Hypertension200137242943210.1161/01.HYP.37.2.429 11230313
     [Google Scholar]
  46. MuJ. ZhengS. LianQ. LiuF. LiuZ. Evolution of blood pressure from adolescents to youth in salt sensitivies: A 18-year follow-up study in Hanzhong children cohort.Nutr. J.20121117010.1186/1475‑2891‑11‑70 22978814
     [Google Scholar]
  47. BihoracA. TezcanH. ÖzenerC. OktayA. AkogluE. Association between salt sensitivity and target organ damage in essential hypertension.Am. J. Hypertens.200013886487210.1016/S0895‑7061(00)00253‑3 10950394
     [Google Scholar]
  48. SandersP.W. Dietary salt intake, salt sensitivity, and cardiovascular health.Hypertension200953344244510.1161/HYPERTENSIONAHA.108.120303 19153264
     [Google Scholar]
  49. LandeM.B. FlynnJ.T. Treatment of hypertension in children and adolescents.Pediatr. Nephrol.200924101939194910.1007/s00467‑007‑0573‑4 17690916
     [Google Scholar]
  50. PescatelloL.S. BuchnerD.M. JakicicJ.M. Physical activity to prevent and treat hypertension: A systematic review.Med. Sci. Sports Exerc.20195161314132310.1249/MSS.0000000000001943 31095088
     [Google Scholar]
  51. AbasHidayat DidiTaswidi AlifaRomadoni RomadoniA. Effect of hypertension exercise on blood pressure in the elderly.World J Adv Res Rev202213349149510.30574/wjarr.2022.13.3.0269
     [Google Scholar]
  52. HerawatiI. Mat LudinA.F. M M, Ishak I, Farah NMF. Breathing exercise for hypertensive patients: A scoping review.Front. Physiol.202314104833810.3389/fphys.2023.1048338 36760529
     [Google Scholar]
  53. LuY. ChenR. CaiJ. HuangZ. YuanH. The management of hypertension in women planning for pregnancy.Br. Med. Bull.20181281758410.1093/bmb/ldy035 30371746
     [Google Scholar]
  54. MuscogiuriG. VerdeL. SuluC. Mediterranean diet and obesity-related disorders: What is the evidence?Curr. Obes. Rep.202211428730410.1007/s13679‑022‑00481‑1 36178601
     [Google Scholar]
  55. FigueiredoA.E. UrbanettoJ.S. MagnagoT.S.B.S. Poli-de-FigueiredoC.E. Psychosocial stress and hypertension in nursing staff.Clin. Nurs. Stud.20153410.5430/cns.v3n4p15
     [Google Scholar]
  56. IlmaskalR. WatiL. MonarisaM. MailitaW. RahmiA. JepisaT. The impact of tera gymnastics on the reduction of hypertension in the elderly.J Health Sains202341566310.46799/jhs.v4i1.789
     [Google Scholar]
  57. HassanA.M. KamelS.M.M. ToradA. HazzaaA. SalamaA.M. Effect of wet cupping therapy on reducing blood pressure in primary hypertensive patients: A preliminary study.Inter. J. Med. Sci.20236147648310.21608/svuijm.2022.175851.1453
     [Google Scholar]
  58. TuckerK.L. SheppardJ.P. StevensR. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.PLoS Med.2017149100238910.1371/journal.pmed.1002389 28926573
     [Google Scholar]
  59. AbdullahA. OthmanS. The influence of self-owned home blood pressure monitoring (HBPM) on primary care patients with hypertension: A qualitative study.BMC Fam. Pract.201112114310.1186/1471‑2296‑12‑143 22208768
     [Google Scholar]
  60. ChaturvediS. LipszycD.H. LichtC. CraigJ.C. ParekhR. Pharmacological interventions for hypertension in children.Evid. Based Child Health20149349858010.1002/ebch.1974 25236305
     [Google Scholar]
  61. RobinsonR.F. NahataM.C. BatiskyD.L. MahanJ.D. Pharmacologic treatment of chronic pediatric hypertension.Paediatr. Drugs200571274010.2165/00148581‑200507010‑00003 15777109
     [Google Scholar]
  62. StephensM.M. FoxB.A. MaxwellL. Therapeutic options for the treatment of hypertension in children and adolescents.Clin. Med. Insights Circ. Respir. Pulm. Med.20126132510.4137/CCRPM.S7602
     [Google Scholar]
  63. SeikalyM.G. Bahlawan-SeikalyS. Strategies of treatment of pediatric hypertension.J. Med. Liban.2010583161166 21462846
     [Google Scholar]
  64. BloweyD.L. Antihypertensive agents: Mechanisms of action, safety profiles, and current uses in children.Curr. Ther. Res. Clin. Exp.200162429831310.1016/S0011‑393X(01)80014‑X
     [Google Scholar]
  65. SeikalyM.G. Hypertension in children: An update on treatment strategies.Curr. Opin. Pediatr.200719217017710.1097/MOP.0b013e32801da292 17496761
     [Google Scholar]
  66. TempleM.E. NahataM.C. Treatment of pediatric hypertension.Pharmacotherapy200020214015010.1592/phco.20.3.140.34782 10678292
     [Google Scholar]
  67. FeldL.G. CoreyH. Hypertension in Childhood.Pediatr. Rev.200728828329810.1542/pir.28.8.283 17670953
     [Google Scholar]
  68. SmithS.M. AndersonS.D. WenS. Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: Subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.Pharmacotherapy200929101157116510.1592/phco.29.10.1157 19792989
     [Google Scholar]
  69. Evaluation of the prevalence and clinical manifestation of SARS-CoV-2 infection in a population of adult and pediatric patients with congenital heart disease.NCT Patent 067846872025
  70. Pediatric ventricle function assessment study.NCT Patent 067390572024
  71. Hypertension in high school students (HYGEF).NCT Patent 060496412024
  72. Flow-mediated arterial dilatation, hypertension, endothelin-1 and sICAM-1 in obese adolescents (sICAM-1).NCT Patent 059518942023
  73. Management of acute pulmonary hypertensive crisis in children with known pulmonary arterial hypertension.NCT Patent 054394602022
  74. Family meals on prescription - A randomized controlled trial.NCT Patent 052253502022
  75. The effect of caudal block on optic nerve sheath diameter in pediatric patients.NCT Patent 052162112022
  76. Exercise capacity respiratory muscle strength dyspnea and physical activity in pediatric pulmonary arterial hypertension.NCT Patent 051240152025
  77. A study of azilsartan in children from 6 to less than 16 years old with high blood pressure.NCT Patent 051079602024
  78. The role of transthoracic echocardiography in diagnosis of pulmonary hypertension of infants with bronchopulmonary dysplasia.NCT Patent 050822722021
  79. Pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) in cystic fibrosis related liver disease.NCT Patent 050376432021
  80. NEURodevelopmental outcome after persistent pulmonary hypertension of the newborn (NEUROPHON).NCT Patent 048410702021
  81. Observational study of actigraphy in pediatric pulmonary arterial hypertension.NCT Patent 047450002023
  82. Obesity in pediatric sickle cell disease: A new phenomenon.NCT Patent 046761132023
  83. A study of TAK-536 in children from 2 to less than 6 years old with high blood pressure.NCT Patent 046681572024
  84. Assessing the feasibility of N-of-1 trials in children with hypertension and chronic kidney disease.NCT Patent 045911712023
  85. Association of mood with risk for atherosclerosis (AuRA).NCT Patent 042989442022
  86. Before-after comparison of pharmacist drug therapy management in pediatric hypertension.NCT Patent 040989782022
  87. Best rest: Rest time before blood pressure measurement trial.NCT Patent 040317682022
  88. Be-HealthY: Behavioral risk factors for poor vascular health in youth.NCT Patent 039343982022
  89. Enteral L citrulline supplementation in preterm infants - Safety, efficacy and dosing.NCT Patent 036499322021
  90. Response of the gut microbiome and circulating metabolome to diet in children: Ancillary study to KIDFIT (NCT03405246).NCT Patent 036124792022
  91. Image-based multi-scale modeling framework of the cardiopulmonary system: Longitudinal calibration and assessment of therapies in pediatric pulmonary hypertension.NCT Patent 035645222024
  92. N-of-1 trials in children with hypertension (NICHE).NCT Patent 034610032022
  93. Efficacy of beraprost in lowering pulmonary arterial pressure in children.NCT Patent 034316492018
  94. Revatio special investigation for long-term use in pediatric patients.NCT Patent 033642442022
  95. Effects of diet on pregnancy outcome and child obesity.NCT Patent 032327622019
  96. Erythrocyte glutamine level relation to pulmonary hypertension risk in beta thalassemia major children.NCT Patent 031331692019
  97. Evaluating the impact of a community health worker program in Neno, Malawi.NCT Patent 031067272019
  98. Sportcheck follow-up.NCT Patent 030854982018
  99. Frailty in children with cardiac disease.NCT Patent 029994382023
  100. Actigraphy in pediatric pulmonary hypertension.NCT Patent 029096082021
  101. Study of Remodulin® in pediatric pulmonary hypertension with single ventricular physiology after fontan surgery.NCT Patent 028657332020
  102. Exercise and arterial modulation in youth (ExAMIN YOUTH).NCT Patent 028537472023
  103. A phase 3 long-term study of TAK-536 in pediatric patients 6 to less than 16 Years with hypertension.NCT Patent 027914382020
  104. Families on track: A digital health behavioral intervention for parents seeking treatment for their child with obesity.NCT Patent 027674402017
  105. Tracking outcomes and practice in pediatric pulmonary hypertension (TOPP-2).NCT Patent 026106602023
  106. Epidemiology and treatment patterns of paediatric PAH (Pulmonary Arterial Hypertension).NCT Patent 025760022016
/content/journals/chyr/10.2174/0115734021400792250807110550
Loading
Advancing Pediatric Hypertension: Mechanism Insights, Clinical Trials and Innovation
Current Hypertension Reviews 21, 217 (2025); https://doi.org/10.2174/0115734021400792250807110550
/content/journals/chyr/10.2174/0115734021400792250807110550
/content/journals/chyr/10.2174/0115734021400792250807110550
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): clinical trials; epidemiology; hypertension; management; pathophysiology; Pediatric hypertension

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test